Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm

Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm

The outburst of inflammatory response and hypercoagulability are among the factors contributing to increased mortality in severe COVID-19 cases. Pentoxifylline (PTX), a xanthine-derived drug registered for the treatment of vascular claudication, has been reported to display broad-spectrum anti-infla...

Full description

Bibliographic Details
Main Authors: Wiktoria Feret, Magdalena Nalewajska, Łukasz Wojczyński, Wojciech Witkiewicz, Patrycja Kłos, Violetta Dziedziejko, Andrzej Pawlik
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
SARS-CoV-2
cytokine storm
cytokines
pentoxifylline
pneumonia
Online Access:https://www.mdpi.com/2077-0383/10/22/5305

Internet

https://www.mdpi.com/2077-0383/10/22/5305

Similar Items